Overexpression of Deubiquitinase (usp 36) in Oral Squamous Cell Carcinoma

Overview

Journal J Oral Maxillofac Pathol

Date 2024 Feb 2

PMID 38304515

Authors

Preethi Murali

B Kavitha

Malathi Narasimhan

Affiliations

Soon will be listed here.

Abstract

Aim: Oral cancer is one of the top three types of cancer and is of significant public health importance in India. A common post-translational modification in cells is ubiquitination/deubiquitination, and its dysregulation is closely associated with the development of cancer. Studies on the role of ubiquitination in oral squamous cell carcinoma (OSCC) are lacking. Increased expression of has been observed in various types of cancer, and this study aimed to check the gene expression of in OSCC patients. In this study, we analyzed the expression of ubiquitin-specific proteases (USPs) 36 in OSCC.

Materials And Methods: A total of 15 OSCC patients at different stages of tumor differentiation and age- and sex-matched controls were recruited for the study. The patients were categorized based on their differentiation patterns. RNA was extracted from the tissues, and gene expression was checked in these samples using a quantitative real-time PCR technique.

Results: Our study showed increased expression of gene in OSCC patients. The mRNA was 231.8 ± 137.94 folds higher in well-differentiated squamous cell carcinoma patients, 38.18 ± 3.77 folds higher in moderately differentiated squamous cell carcinoma patients, and 25.49 ± 7.30 folds higher in poorly differentiated squamous cell carcinoma patients compared to control tissues.

Conclusion: Our study reports, for the first time, an increased gene expression of in OSCC tissues.

References

Schrader E, Harstad K, Matouschek A . Targeting proteins for degradation. Nat Chem Biol. 2009; 5(11):815-22. PMC: 4228941. DOI: 10.1038/nchembio.250. View

Deng L, Meng T, Chen L, Wei W, Wang P . The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020; 5(1):11. PMC: 7048745. DOI: 10.1038/s41392-020-0107-0. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Borse V, Konwar A, Buragohain P . Oral cancer diagnosis and perspectives in India. Sens Int. 2021; 1:100046. PMC: 7515567. DOI: 10.1016/j.sintl.2020.100046. View

Deng Q, Wu M, Deng J . USP36 promotes tumor growth of non-small cell lung cancer via increasing KHK-A expression by regulating c-MYC-hnRNPH1/H2 axis. Hum Cell. 2022; 35(2):694-704. DOI: 10.1007/s13577-022-00677-6. View

Kademani D, Bell R, Bagheri S, Holmgren E, Dierks E, Potter B . Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg. 2005; 63(11):1599-605. DOI: 10.1016/j.joms.2005.07.011. View

Sears R . The life cycle of C-myc: from synthesis to degradation. Cell Cycle. 2004; 3(9):1133-7. View

. Oral cancer - the fight must go on against all odds…. Evid Based Dent. 2022; 23(1):4-5. DOI: 10.1038/s41432-022-0243-1. View

Coelho K . Challenges of the oral cancer burden in India. J Cancer Epidemiol. 2012; 2012:701932. PMC: 3471448. DOI: 10.1155/2012/701932. View

10.

Shi D, Grossman S . Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets. Cancer Biol Ther. 2010; 10(8):737-47. PMC: 3023568. DOI: 10.4161/cbt.10.8.13417. View

11.

Kumar S, Heller R, Pandey U, Tewari V, Bala N, Oanh K . Delay in presentation of oral cancer: a multifactor analytical study. Natl Med J India. 2001; 14(1):13-7. View

12.

Williams H . Molecular pathogenesis of oral squamous carcinoma. Mol Pathol. 2000; 53(4):165-72. PMC: 1186964. DOI: 10.1136/mp.53.4.165. View

13.

Sears R, Leone G, DeGregori J, Nevins J . Ras enhances Myc protein stability. Mol Cell. 1999; 3(2):169-79. DOI: 10.1016/s1097-2765(00)80308-1. View

14.

Shachaf C, Kopelman A, Arvanitis C, Karlsson A, Beer S, Mandl S . MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 2004; 431(7012):1112-7. DOI: 10.1038/nature03043. View

15.

Adhikary S, Eilers M . Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol. 2005; 6(8):635-45. DOI: 10.1038/nrm1703. View

16.

Pfaffl M . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. PMC: 55695. DOI: 10.1093/nar/29.9.e45. View

17.

Farrell A, Sears R . MYC degradation. Cold Spring Harb Perspect Med. 2014; 4(3). PMC: 3935390. DOI: 10.1101/cshperspect.a014365. View

18.

Kim M, Kim Y, Kim Y, Seong M, Choi J, Baek K . Deubiquitinating enzyme USP36 contains the PEST motif and is polyubiquitinated. Biochem Biophys Res Commun. 2005; 330(3):797-804. DOI: 10.1016/j.bbrc.2005.03.051. View

19.

Kim M, Ramakrishna S, Lim K, Kim J, Baek K . Protein stability of mitochondrial superoxide dismutase SOD2 is regulated by USP36. J Cell Biochem. 2011; 112(2):498-508. DOI: 10.1002/jcb.22940. View

20.

Li J, Olson L, Zhang Z, Li L, Bidder M, Nguyen L . Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer. Int J Med Sci. 2008; 5(3):133-42. PMC: 2424181. DOI: 10.7150/ijms.5.133. View